New antivirals are urgently needed. Recent outbreaks caused by viruses with great epidemiological impact such as Zika, or extraordinary virulence such as Ebola, Nipah, Lassa, Crimean-Congo haemorrhagic fever highlight the current lack of clinically proven vaccines and treatments for these potentially catastrophic agents. Antiviral Discovery for Highly Pathogenic Emerging Viruses will comprehensively outline the state of the art in antiviral drug discovery including identification of targets, screening, strategies, and the current pipeline of candidate antivirals. The book will also address the challenges faced in proceeding from pre-clinical studies to animal models and clinical trials with these highly pathogenic agents.